Filing Flows › Comparisons › INNV vs WGS
InnovAge Holding vs GeneDx Holdings: INNV and WGS compared
InnovAge Holding is the larger company: $265M of revenue in its latest quarter (Q1 FY27) against $123M for GeneDx Holdings (Q3 2026). InnovAge Holding is growing faster (+12% against +5% a year earlier). InnovAge Holding is more profitable, with an operating margin of 7.6% against -8.5%.
Where the money goes: INNV and WGS
InnovAge Holding (INNV) · Q1 FY27
InnovAge Holding, Q1 FY27: revenue $265M (+12% year over year), operating margin 7.6%, net earnings $19.6M, operating cash flow $28.7M. The chart follows the revenue to costs, profit and cash.
GeneDx Holdings (WGS) · Q3 2026
GeneDx Holdings, Q3 2026: revenue $123M (+5% year over year), operating margin -8.5%, net loss $12.3M, operating cash flow −$10.6M. The chart follows the revenue to costs, profit and cash.
| InnovAge Holding (INNV) | GeneDx Holdings (WGS) | |
|---|---|---|
| Latest quarter | Q1 FY27 | Q3 2026 |
| Revenue | $265M | $123M |
| Revenue growth, Y/Y | +12% | +5% |
| Gross margin | 24.0% | — |
| Operating margin | 7.6% | -8.5% |
| Net earnings | $19.6M | −$12.3M |
| Net margin | 7.4% | -10.0% |
| Operating cash flow | $28.7M | −$10.6M |
| Free cash flow | $25.8M | — |
| Market value | — | $2.0B |
| Analysts’ mean target | — | $93.50 |
Where the revenue comes from
GeneDx Holdings
- Diagnostic Test: $120M (97%)
- Other revenue: $3.0M (2%)
Questions
Which is bigger, InnovAge Holding or GeneDx Holdings?
InnovAge Holding is the larger company: $265M of revenue in its latest quarter (Q1 FY27) against $123M for GeneDx Holdings (Q3 2026).
Is InnovAge Holding or GeneDx Holdings growing faster?
InnovAge Holding is growing faster (+12% against +5% a year earlier).
Which is more profitable, InnovAge Holding or GeneDx Holdings?
InnovAge Holding is more profitable, with an operating margin of 7.6% against -8.5%.
More: InnovAge Holding earnings · how InnovAge Holding makes money · GeneDx Holdings earnings · how GeneDx Holdings makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Nov 3, 2026; 10-Q filed Nov 9, 2026). Fiscal quarters can end on different dates. Not investment advice.